Télécharger le texte intégral - ISPED-Enseignement à distance

181
137. Martinson N, Morris L, Gray G, Moodley D, Lupondwana P, Chezzi C, et al. HIV Resistance
and Transmission following Single-dose Nevirapine in a PMTCT Cohort. 11 th Conference on
Retroviruses and Opportunistic Infection; February 8-11, 2004; San Francisco, USA (abstract
38)
138. Delfraissy JF. Prise en charge thérapeutique des personnes infectées par le VIH. Médecine-
Science Flammarion ed. Paris; 2004.
139. Chaix M, Montcho C, Ekouevi D, Rouet F, Bequet L, Viho I, et al. Genotypic Resistance
Analysis in Women Who Received Intrapartum Nevirapine Associated to a Short Course of
Zidovudine to Prevent Perinatal HIV-1 Transmission: The Ditrame Plus ANRS 1201/02
Study, Abidjan, Côte d'Ivoire. 11 th Conference on Retroviruses and Opportunistic Infection;
February 8-11, 2004; San Francisco, USA (abstract 657).
140. Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, et al.
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to
prevent HIV-1 vertical transmission. AIDS 2000;14(11):F111-F115.
141. Adje-Toure C, Bile CE, Borget MY, Hertog K, Maurice C, Nolan ML, et al. Polymorphism in
protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant
CRF02_AG isolates from patients with no prior use of antiretroviral drugs in Abidjan, Cote
d'Ivoire. J Acquir Immune Defic Syndr 2003;34(1):111-113.
142. Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekouevi DK, et al. Field evaluation of an
improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1
CRF02_AG strains in Cote d'Ivoire, West Africa. J Acquir Immune Defic Syndr
2003;34(3):267-273.
143. Sawadogo S, Adje-Toure C, Bile CE, Ekpini RE, Chorba T, Nkengasong JN. Field evaluation
of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant
forms of human immunodeficiency virus type 1 in Abidjan, Cote d'Ivoire. J Clin Microbiol
2003;41(7):3056-3059.
144. Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, et al. Presence of
key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire:
ANRS 1257 study. AIDS Res Hum Retroviruses 2003;19(8):713-717.
145. Chaix ML, Descamps D, Harzic M, Schneider V, Deveau C, Tamalet C, et al. Stable
prevalence of genotypic drug resistance mutations but increase in non-B virus among patients
with primary HIV-1 infection in France. AIDS 2003;17(18):2635-2643.
146. Masquelier B, Race E, Tamalet C, Descamps D, Izopet J, Buffet-Janvresse C, et al. Genotypic
and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with
insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated
with RT inhibitors. Antimicrob Agents Chemother 2001;45(6):1836-1842.
147. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial
dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet
1999;354(9184):1084-1089.
148. Barret B, Tardieu M, Rustin P, Lacroix C, Chabrol B, Desguerre I, et al. Persistent
mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a
large prospective cohort. AIDS 2003;17(12):1769-1785.